期刊文献+

乳腺癌组织分化程度及月经状况与泌乳素受体关系 被引量:1

下载PDF
导出
摘要 目的探讨乳腺癌组织学分级及患者月经状况与泌乳素受体(PRL-R)表达间的关系。方法对130例乳腺癌患者采用免疫组化法配合单克隆抗体检测各病例原发灶标本蜡块中PRL-R的表达,并与组织学分级及患者月经状况展开相关性分析。结果130例患者中PRL-R阳性表达89例,阳性率为68.5%。PRL-R表达阳性与肿瘤组织学分级呈负相关(rs=-0.275,P<0.05),与患者是否绝经无关联(P>0.05)。结论乳腺癌随肿瘤组织分化程度下降,PRL-R表达阳性亦呈下降趋势。乳腺癌患者绝经与否对PRL-R表达阳性影响不大。
出处 《广东医学》 CAS CSCD 北大核心 2008年第10期1678-1679,共2页 Guangdong Medical Journal
  • 相关文献

参考文献10

  • 1郑旭琴,孙敏,刘超.催乳素与人类肿瘤关系的新认识[J].国外医学(内分泌学分册),2004,24(2):111-113. 被引量:13
  • 2GUTZMAN J H, RUGOWSKI D E, SCHROEDER M D, et al. Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells[J]. Mol Endocfinol, 2004, 18 (12): 3064-3075.
  • 3LIBY K, NELTNER B, MOHAMET L, et 81. Prolactin overexpression by MDA- MB -435 human breast cancer cells accderates tumor growth[J]. Breast Cancer Res Treat, 2003, 79(2) : 241 -252.
  • 4杨竹林,许建晃,杨元华,李永国.乳腺良恶性病变组织中ER,PR,PRL,6PGDH和ICDH的分布及在乳腺癌中相互关系[J].肿瘤防治研究,1995,22(2):82-84. 被引量:3
  • 5CHRISTOPHER J, ORMAND Y, ROSEMARY E, et al. Coexpression and cross - regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer[J]. J Clin Endocrinol Metab, 1997, 82(11) : 3 692 -3 699.
  • 6GILL D, PKSTON B K, VONDERHAAR S, et al. Expression of prolactin receptors in normal, benign, and malignant breast tissue: an inununohistologlcal study[J]. J Clin Pathol, 2001, 54:956-960.
  • 7BONNETERRE J P, BEUSCART P R. Correlation between prolactin receptor (PR L- R), estradiol(ER) and prolactin receptor (PR) in human breast cancer[J]. Eur J Clin Oncol, 1986, 22 (11): 1331-1336.
  • 8关晏星,雷秋模,王莉,张芸,段红华,吴根秀.泌乳素受体与乳腺癌预后因素的相关性研究[J].中国肿瘤临床,2002,29(1):5-8. 被引量:7
  • 9WASEDA N, KATO Y, LMURA H, et al. Prognostic value of estrogen and prolactln receptor analysis in human breast cancer[ J]. Jpn J Cancer Res, 1985, 76(16) : 517 -523.
  • 10DE PLACIDO S, GALLO C, PERRONE F, et al. Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study[J]. Br J Cancer, 1990, 62(4): 643 -646.

二级参考文献13

  • 1张信美.泌乳素的研究进展[J].国外医学(妇产科学分册),1995,22(3):133-137. 被引量:8
  • 2Melck D, De Petrocells L, Orlando L, et al. Suppression of never growth factor trk. Receptor and prolactin receptor by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology, 2000,141:118-126.
  • 3Ben-Jonathan N,Liby K, McFarland M, et al. Prolactin as an autocrine/paracrine growth factor in human cancer. Trends Endocrinol Metab, 2002,13:245-250.
  • 4Leav I, Merk FB , Lee KF, et al. Prolactin receptor expression in the developing human prostate and in hyperplastic,dysplastic,and neoplastic lesions.Am J Pathol, 1999,154:863-870.
  • 5Nowak RA, Mora S, Diehl T, et al. Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. Gynecol Obstet Invest,1999,48:127-132.
  • 6Freeman ME, Kanyicska B, Lerant A, et al. Prolactin: structure, function, and regulation of secretion. Physiol Rev,2000,80:1523-1631.
  • 7Gambino GM, Beck-Peccoz P, Borgato S, et al. Bioactivity and glycosylation of circulating prolactin in various physiological and pathological conditions.Pituitary,1999,2:225-231.
  • 8Leondires MP, Hu ZZ, Dong J, et al. Estradiol stimulates expression of two human prolactin receptor isoforms with alternative exons-1 in T47D breast cancer cells. J Steroid Biochem Mol Biol,2002,82:263-268.
  • 9Schroeder MD, Symowicz J, Schuler LA. PRL modulates cell cycle regulators in mammary tumor epithelial cells. Mol Endocrinol,2002,16:45-57.
  • 10Bhatavdekar JM, Patel DD, Shah NG, et al. Prolactin as a local growth promoter in patients with breast cancer:GCRI experience. Eur J Surg Oncol,2000,26:540-547.

共引文献18

同被引文献21

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部